Category Archives: Uncategorized

#MalditosSionistas? SÍ. ¡Alto al genocidio sionista! | #IStandByIsrael? NO. End Zionist Genocide!

Zapatista MX: #MalditosSionistas? SÍ. ¡Alto al genocidio sionista! | #IStandByIsrael? NO. End Zionist Genocide!


#MalditosSionistas? SÍ. Soldados israelíes sionistas disparan niña palestina desarmados y la dejan morir desangrado.

En este video editado por la agencia PalMedia aparece una joven palestina desangrándose sobre una acera de la ciudad ocupada de Hebrón, en Cisjordania, después de que el martes por la mañana unos soldados israelíes le dispararan en un puesto de control. Por la tarde, los medios palestinos informaban que la mujer, de 18 años de edad y de nombre Hadil Salah Hashlamun, había muerto a causa de las heridas de bala. En vez de procurarle atención médica de inmediato, el video muestra cómo es arrastrada para sacarla del objetivo de la cámara mientras su cabeza se golpea contra el suelo. A su alrededor puede verse a varios soldados y colonos, que en algunos momentos comentan y ríen ante la escena.

Leer Más…


#IStandByIsrael? NO. Zionist Israeli soldiers shoot unarmed Palestinian girl and leave her to bleed to death.

This video posted by the news agency PalMedia shows a young Palestinian woman left to bleed on a sidewalk in the occupied West Bank city of Hebron after she was shot by Israeli soldiers on Tuesday morning. By evening, Palestinian media reported that the woman, 18-year-old Hadil Salah Hashlamoun, had died of her injuries. Instead of being given immediate medical treatment, the video shows her being pulled roughly out of the frame of the camera, her scarf coming off as her head drags on the ground. Israeli settlers and soldiers can be seen standing around, and in some cases smiling and laughing in the background.

Read More…

For McKesson Corporation, the Mission is Price Manipulation

For McKesson Corporation, the Mission is Price Manipulation

With 2010 revenues of $108.7 billion and earnings of $1.2 billion, McKesson Corporation ranks #15 on the Fortune 500.  It is the nation’s largest healthcare provider, with pharmaceuticals distribution being the backbone of the company:  One-third of all medicines used in the U.S. run through the McKesson pipeline.  The company is also the dominant player in healthcare information systems, as more than 70% of our major hospitals use its technology to digitize prescriptions and patient medical records.

McKesson is also one of the U.S. government’s largest contractors with billions in federal contracts awarded annually, over $4.6 billion in 2010 alone.  It also ranks high in the POGO (Project On Government Oversight) Federal Contractor Misconduct Database (FCMD), with 14 documented instances of misconduct totalling more than $1.3 billion.

Aside from a history of securities fraud beginning with the infamous McKesson-Robbins scandal of 1938 to their more recent McKessonHBOC debacle, the focus of McKesson’s white-collar criminal activity is the manipulation of prices paid for pharmaceuticals.  As they compete with the CIA for the “America’s Drug Dealer” moniker, obviously the more they charge for each prescription that moves through their pipeline the more money they make.  Here’s a judge’s description of how one of their recent schemes worked:

“Beginning in 2001, FDB and McKesson reached a secret agreement to raise the markup between WAC (wholesale average cost)and AWP (average wholesale price) from its standard 20% to 25% for over four hundred drugs. … McKesson communicated these new 25% WAC to AWP markups to FDB, which then published AWPs with the new markup…  McKesson has estimated that by 2002, 95% of all prescription drug manufacturers used the inflated 25% markup, and by 2004, 99% of all prescription drug manufacturers did so. … The scheme ended on March 15, 2005, when FDB told its customers that it would ‘no longer survey drug wholesalers for information relating to’ AWP.  The scheme resulted in higher profits for retail pharmacies that purchase drugs on the basis of WAC but are reimbursed on the basis of AWP, a differential called ‘the spread’. … McKesson implemented the scheme in order to provide a greater ‘spread’ to important retail pharmacy clients like Rite Aid as well as to its own pharmacy related businesses.”

Nobody went to jail over this, but thanks to a class-action lawsuit McKesson was forced to pay a $350 million penalty:

“The prices of about 1,400 branded drugs are about to get a little cheaper because of a $352.7 million class action settlement with wholesale drug distributor McKesson…  In addition to the payment, the prices of 1,442 medicines will be lowered by 4 percent, according to a federal court ruling…  The court-approved deal wraps up a lengthy case in which McKesson and First Databank were accused of engaging in a ‘racketeering enterprise to fraudulently increase the published ‘average wholesale price’ (‘AWP’) of over four hundred branded drugs by five percent from late 2001 to 2005,’ Judge Patti Saris wrote.  MediSpan published the same false prices…  Affected drugs include Lipitor, Claritin, Prozac, Nexium, Plavix, Allegra, Wellbutrin, Ambien, Prilosec, Zantac, Valtrex, Zyprexa, Celebrex, Imitrex, Risperdal, Seroquel, and Neurontin.”

In April 2011 the U.S. Supreme Court decision in the “AT&T Mobility v. Concepcion” case made it easy for corporations to shield themselves from class action lawsuits like this going forward.  But even if that shield is taken away, McKesson has an ample $442 million litigation reserve set aside so they can continue to focus on profits regardless of propriety:

Related Image:

Related Videos:

This document contains links shortened using to facilitate emailing.  If you are concerned that we would use them to cloak phishing or malware, you should open them with this:

The Pfelons of Pfizer: Too Crooked to Fail and Don’t Go to Jail

The Pfelons of Pfizer: Too Crooked to Fail and Don't Go to Jail

Global Revolution 1: American Revolution 2: Day 52: Communication 1
IronBoltBruce’s Kleptocracy Chronicles for 7 Nov 2011 (g1a2d0052c1)
How many examples of greed and corruption must you see before you act?

With 2010 revenues of $67.8 billion and profits of $8.2 billion, Pfizer Inc. ranks #31 on the Fortune 500 and is the world’s largest pharmaceuticals corporation.  Brand names include Viagra, Celebrex, Norvasc, and Lipitor.  The company also manufactures animal care products such as Revolution, an anti-parasitic.  In 2009, Pfizer acquired its rival Wyeth for 68 billion dollars.  Wyeth’s over the counter brands included Advil, Centrum, Robitussin and ChapStick.  The majority of its sales are conducted through the wholesale companies McKesson and Cardinal Health.  Here is a complete listing of the Pfizer’s products:

Since 1989 Pfizer has contributed over $21 million to federal and state politicians, with George W. Bush and Barack Obama being the top recipients.  And since 1999 the company has spent more than $105 million in lobbying on issues that have more to do with Pfizer’s wealth than America’s health.

In return for their political payola and lobbying investment, Pfizer has been awarded over $5 billion in U.S. government contracts over the past few years, mostly for drugs ordered by the Departments of Defense and Veterans Affairs:

At the same time Uncle Sam was handing billions of your tax dollars over to Pfizer, he was spending millions more investigating their illegal activities.  As reported by the New York Times on 3 September 2009…

“The pharmaceutical giant Pfizer agreed to pay $2.3 billion to settle civil and criminal allegations that it had illegally marketed its painkiller Bextra, which has been withdrawn.  It was the largest health care fraud settlement and the largest criminal fine of any kind ever…  It was Pfizer’s fourth settlement over illegal marketing activities since 2002…  The government charged that executives and sales representatives throughout Pfizer’s ranks planned and executed schemes to illegally market not only Bextra but also Geodon, an antipsychotic; Zyvox, an antibiotic; and Lyrica, which treats nerve pain.  While the government said the fine was a record sum, the $2.3 billion fine amounts to less than three weeks of Pfizer’s sales.  Much of the activities cited Wednesday occurred while Pfizer was in the midst of resolving allegations that it illegally marketed Neurontin, an epilepsy drug for which the company in 2004 paid a $430 million fine and signed a corporate integrity agreement – a companywide promise to behave.  John Kopchinski, a former Pfizer sales representative whose complaint helped prompt the government’s Bextra case, said that company managers told him and others to dismiss concerns about the Neurontin case while pushing them to undertake similar illegal efforts on behalf of Bextra.  ‘The whole culture of Pfizer is driven by sales, and if you didn’t sell drugs illegally, you were not seen as a team player,’ said Mr. Kopchinski, whose personal share of the Pfizer settlement is expected to exceed $50 million. Mr. Kopchinski left Pfizer in 2003.  Altogether, six whistle-blowers will collect $102 million from the federal share of the settlement and more from states’ shares.  Forty-nine states and the District of Columbia will collect $331 million, with New York State alone getting $66 million.  Only South Carolina chose not to participate in the settlement…  As news of the riches earned by whistle-blowers spread through the industry in recent years, scores of fraud cases have been filed by former drug sales representatives using a Civil War-era law that pays a bounty for fraud alerts.  The cases charge that illegal drug marketing cost the federal Medicare and Medicaid program millions.”

Will a fine of only three week’s sales change the greedy corporate culture at Pfizer, or simply be viewed as a small price to pay for billions of dollars in profits annually from illegal operations, including crimes against humanity?

“Sidney Wolfe, director of Public Citizen’s Health Research Group, said the Pfizer settlement ‘may sound large, but it’s not enough to ensure drug companies will curb their bad behavior.’  Wolfe pointed out that the Pfizer agreement topped a landmark settlement set by Eli Lilly in January, when that company paid more than $500 million in criminal penalties for improper marketing of the antipsychotic drug Zyprexa.  Five other major drug manufacturers logged smaller settlements over the past decade…  ‘The U.S. pharmaceutical industry, long one of the most profitable in the country, with profits last year of close to $50 billion, has engaged in an unprecedented amount of criminal activity in the past decade,’ Wolfe said. ‘Unfortunately, the ever-escalating fines are unlikely to stop drug companies from continuing to bribe doctors because they represent just a fraction of drug company profits and no one has gone to jail.'”

Related Image:

Related Video:

This document contains links shortened using to facilitate emailing.  If you are concerned that we would use them to cloak phishing or malware, you should open them with this: